Cardioembolic Stroke: Practical Considerations for Patient Risk Management and Secondary Prevention

References

• . Sandercock PA, Warlow CP, Jones LN, Starkey IR. Predisposing factors for cerebral infarction: the Oxfordshire community stroke project. BMJ. 1989;298(6666):75–80
   PubMedGoogle Scholar
• . Furie KL, Kasner SE, Adams RJ, . Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42(1):227–276
   PubMed Web of Science ®Google Scholar
• . Bogousslavsky J, Cachin C, Regli F, Despland PA, Van Melle G, Kappenberger L. Cardiac sources of embolism and cerebral infarction-clinical consequences and vascular concomitants: the Lausanne Stroke Registry. Neurology. 1991;41(6):855–859
   PubMedGoogle Scholar
• . Saxena R, Lewis S, Berge E, Sandercock PA, Koudstaal PJ. Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke. 2001;32(10):2333–2337
   PubMedGoogle Scholar
• . Cheitlin MD, Armstrong WF, Aurigemma GP, . ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation. 2003;108(9):1146–1162
   PubMed Web of Science ®Google Scholar
• . Pearson AC, Labovitz AJ, Tatineni S, Gomez CR. Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol. 1991;17(1):66–72
   PubMed Web of Science ®Google Scholar
• . Harloff A, Handke M, Reinhard M, Geibel A, Hetzel A. Therapeutic strategies after examination by transesophageal echocardiography in 503 patients with ischemic stroke. Stroke. 2006;37(3):859–864
   PubMedGoogle Scholar
• . DeRook FA, Comess KA, Albers GW, Popp RL. Transesophageal echocardiography in the evaluation of stroke. Ann Intern Med. 1992;117(11):922–932
   PubMedGoogle Scholar
• . Miyasaka Y, Barnes ME, Gersh BJ, . Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114(2):119–125
   PubMed Web of Science ®Google Scholar
• . Wolf PA, Kannel WB, McGee DL, Meeks SL, Bharucha NE, McNamara PM. Duration of atrial fibrillation and imminence of stroke: the Framingham study. Stroke. 1983;14(5):664–667
   PubMed Web of Science ®Google Scholar
• . Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001;32(12):2735–2740
   PubMed Web of Science ®Google Scholar
• . Arboix A, García-Eroles L, Massons J, Oliveres M. Predictive clinical factors of in-hospital mortality in 231 consecutive patients with cardioembolic cerebral infarction. Cerebrovasc Dis. 1998;8(1):8–13
   PubMed Web of Science ®Google Scholar
• . Eriksson SE, Olsson JE. Survival and recurrent strokes in patients with different subtypes of stroke: a fourteen-year follow-up study. Cerebrovasc Dis. 2001;12(3):171–180
   PubMedGoogle Scholar
• . Lazzaro MA, Krishnan K, Prabhakaran S. Detection of atrial fibrillation with concurrent holter monitoring and continuous cardiac telemetry following ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis. 2012;21(2):89–93
   PubMedGoogle Scholar
• . Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke. 2004;35(7):1647–1651
   PubMed Web of Science ®Google Scholar
• . Tayal AH, Tian M, Kelly KM, . Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology. 2008;71(21):1696–1701
   PubMed Web of Science ®Google Scholar
• . Gage BF, van Walraven C, Pearce L, . Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation. 2004;110(16):2287–2292
   PubMed Web of Science ®Google Scholar
• . Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285(22):2864–2870
   PubMed Web of Science ®Google Scholar
• . Fuster V, Rydén LE, Cannom DS, . ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114(7):e257–e354
   PubMed Web of Science ®Google Scholar
• . Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M, Committee CAFG. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Can J Cardiol. 2011;27(1):74–90
   PubMed Web of Science ®Google Scholar
• . , European Heart Rhythm Association; European Association for Cardio-Thoracic SurgeryCamm AJ, Kirchhof P, Lip GY, . Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369–2429
   PubMed Web of Science ®Google Scholar
• . Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263–272
   PubMed Web of Science ®Google Scholar
• . Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857–867
   PubMed Web of Science ®Google Scholar
• . Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet. 1996;348(9028):633–638
   PubMed Web of Science ®Google Scholar
• . White HD, Gruber M, Feyzi J, . Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med. 2007;167(3):239–245
   PubMedGoogle Scholar
• . Connolly SJ, Pogue J, Hart RG, . Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009;360(20):2066–2078
   PubMed Web of Science ®Google Scholar
• . Connolly SJ, Ezekowitz MD, Yusuf S, . Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139–1151
   PubMed Web of Science ®Google Scholar
• . Granger CB, Alexander JH, McMurray JJ, . Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981–992
   PubMed Web of Science ®Google Scholar
• . Patel MR, Mahaffey KW, Garg J, . Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883–891
   PubMed Web of Science ®Google Scholar
• . Pradaxa [product monograph]; 2010. www.boehringer-ingelheim.ca. Accessed December 12, 2012
   Google Scholar
• . Xarelto [package insert]; 2012. http://www.xareltohcp.com/sites/default/files/pdf/xarelto_0.pdf#zoom=100. Accessed December 12, 2012
   Google Scholar
• . ELIQUIS [product monograph]; 2012. http://www.pfizer.ca/en/our_products/products/monograph/313. Accessed December 12, 2012
   Google Scholar
• . Chen S, Dong Y, Fan J, Yin Y. Rate vs. rhythm control in patients with atrial fibrillation - an updated meta-analysis of 10 randomized controlled trials. Int J Cardiol. 2011;153(1):96–98
   PubMedGoogle Scholar
• . Wann LS, Curtis AB, January CT, . 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm. 2011;8(1):157–176
   PubMedGoogle Scholar
• . Edgerton ZJ, Edgerton JR. A review of current surgical treatment of patients with atrial fibrillation. Proc (Bayl Univ Med Cent). 2012;25(3):218–223
   PubMedGoogle Scholar
• . Salem DN, Daudelin HD, Levine HJ, Pauker SG, Eckman MH, Riff J. Antithrombotic therapy in valvular heart disease. Chest. 2001;119( 1 Suppl):207S–219S
   PubMed Web of Science ®Google Scholar
• . Wood P. Diseases of the Heart and Circulation. Philadelpia, PA: Lippincott; 1956
   Google Scholar
• . Ellis LB, Harken DE. Arterial embolization in relation to mitral valvuloplasty. Am Heart J. 1961;62:611–620
   PubMedGoogle Scholar
• . Szekely P. Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease. Br Med J. 1964;1(5392):1209–1212
   PubMedGoogle Scholar
• . Deverall PB, Olley PM, Smith DR, Watson DA, Whitaker W. Incidence of systemic embolism before and after mitral valvotomy. Thorax. 1968;23(5):530–536
   PubMedGoogle Scholar
• . Bonow RO, Carabello BA, Chatterjee K, . 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52(13):e1–e142
   PubMed Web of Science ®Google Scholar
• . Benjamin EJ, Plehn JF, D'Agostino RB, . Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med. 1992;327(6):374–379
   PubMed Web of Science ®Google Scholar
• . Savage DD, Garrison RJ, Castelli WP, . Prevalence of submitral (anular) calcium and its correlates in a general population-based sample (the Framingham Study). Am J Cardiol. 1983;51(8):1375–1378
   PubMed Web of Science ®Google Scholar
• . Fulkerson PK, Beaver BM, Auseon JC, Graber HL. Calcification of the mitral annulus: etiology, clinical associations, complications and therapy. Am J Med. 1979;66(6):967–977
   PubMed Web of Science ®Google Scholar
• . Nestico PF, Depace NL, Morganroth J, Kotler MN, Ross J. Mitral annular calcification: clinical, pathophysiology, and echocardiographic review. Am Heart J. 1984;107(5 Pt 1):989–996
   PubMed Web of Science ®Google Scholar
• . Kirk RS, Russell JG. Subvalvular calcification of mitral valve. Br Heart J. 1969;31(6):684–692
   PubMedGoogle Scholar
• . Ridolfi RL, Hutchins GM. Spontaneous calcific emboli from calcific mitral annulus fibrosus. Arch Pathol Lab Med. 1976;100(3):117–120
   PubMedGoogle Scholar
• . Brockmeier LB, Adolph RJ, Gustin BW, Holmes JC, Sacks JG. Calcium emboli to the retinal artery in calcific aortic stenosis. Am Heart J. 1981;101(1):32–37
   PubMedGoogle Scholar
• . Stein PD, Sabbah HN, Pitha JV. Continuing disease process of calcific aortic stenosis. Role of microthrombi and turbulent flow. Am J Cardiol. 1977;39(2):159–163
   PubMed Web of Science ®Google Scholar
• . Edmunds LH. Thrombotic and bleeding complications of prosthetic heart valves. Ann Thorac Surg. 1987;44(4):430–445
   PubMedGoogle Scholar
• . Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl J Med. 1996;335(6):407–416
   PubMed Web of Science ®Google Scholar
• . Cannegieter SC, Rosendaal FR, Briët E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation. 1994;89(2):635–641
   PubMed Web of Science ®Google Scholar
• . Kulik A, Rubens FD, Wells PS, . Early postoperative anticoagulation after mechanical valve replacement: a systematic review. Ann Thorac Surg. 2006;81(2):770–781
   PubMed Web of Science ®Google Scholar
• . Whitlock RP, Sun JC, Fremes SE, Rubens FD, Teoh KH, Physicians ACoC. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141( 2 Suppl):e576S–600S
   PubMed Web of Science ®Google Scholar
• . Singhal AB, Topcuoglu MA, Buonanno FS. Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion-weighted magnetic resonance imaging study. Stroke. 2002;33(5):1267–1273
   PubMedGoogle Scholar
• . Kanter MC, Hart RG. Neurologic complications of infective endocarditis. Neurology. 1991;41(7):1015–1020
   PubMedGoogle Scholar
• . Bamford J, Hodges J, Warlow C. Late rupture of a mycotic aneurysm after “cure” of bacterial endocarditis. J Neurol. 1986;233(1):51–53
   PubMedGoogle Scholar
• . Tornos P, Almirante B, Mirabet S, Permanyer G, Pahissa A, Soler-Soler J. Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy. Arch Intern Med. 1999;159(5):473–475
   PubMedGoogle Scholar
• . Di Tullio MR, Sacco RL, Savoia MT, Sciacca RR, Homma S. Aortic atheroma morphology and the risk of ischemic stroke in a multiethnic population. Am Heart J. 2000;139(2 Pt 1):329–336
   PubMedGoogle Scholar
• . Stone DA, Hawke MW, LaMonte M, . Ulcerated atherosclerotic plaques in the thoracic aorta are associated with cryptogenic stroke: a multiplane transesophageal echocardiographic study. Am Heart J. 1995;130(1):105–108
   PubMedGoogle Scholar
• . Amarenco P, Duyckaerts C, Tzourio C, Hénin D, Bousser MG, Hauw JJ. The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med. 1992;326(4):221–225
   PubMedGoogle Scholar
• . Tunick PA, Kronzon I. Protruding atherosclerotic plaque in the aortic arch of patients with systemic embolization: a new finding seen by transesophageal echocardiography. Am Heart J. 1990;120(3):658–660
   PubMedGoogle Scholar
• . Amarenco P, Cohen A, Baudrimont M, Bousser MG. Transesophageal echocardiographic detection of aortic arch disease in patients with cerebral infarction. Stroke. 1992;23(7):1005–1009
   PubMedGoogle Scholar
• . Harloff A, Strecker C, Dudler P, . Retrograde embolism from the descending aorta: visualization by multidirectional 3D velocity mapping in cryptogenic stroke. Stroke. 2009;40(4):1505–1508
   PubMedGoogle Scholar
• . Lima JA, Desai MY, Steen H, Warren WP, Gautam S, Lai S. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Circulation. 2004;110(16):2336–2341
   PubMedGoogle Scholar
• . Meier B, Frank B, Wahl A, Diener HC. Secondary stroke prevention: patent foramen ovale, aortic plaque, and carotid stenosis. Eur Heart J. 2012;33(6):705–713, 713a, 713b
   PubMedGoogle Scholar
• . Witt BJ, Ballman KV, Brown RD, Meverden RA, Jacobsen SJ, Roger VL. The incidence of stroke after myocardial infarction: a meta-analysis. Am J Med. 2006;119(4):354, e351–359
   PubMedGoogle Scholar
• . Fuster V, Halperin JL. Left ventricular thrombi and cerebral embolism. N Engl J Med. 1989;320(6):392–394
   PubMedGoogle Scholar
• . Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force. Arch Neurol. 1989;46(7):727–743
   PubMedGoogle Scholar
• . Natarajan D, Hotchandani RK, Nigam PD. Reduced incidence of left ventricular thrombi with intravenous streptokinase in acute anterior myocardial infarction: prospective evaluation by cross-sectional echocardiography. Int J Cardiol. 1988;20(2):201–207
   PubMedGoogle Scholar
• . Visser CA, Kan G, Meltzer RS, Lie KI, Durrer D. Long-term follow-up of left ventricular thrombus after acute myocardial infarction. A two-dimensional echocardiographic study in 96 patients. Chest. 1984;86(4):532–536
   PubMedGoogle Scholar
• . Pullicino PM, Halperin JL, Thompson JL. Stroke in patients with heart failure and reduced left ventricular ejection fraction. Neurology. 2000;54(2):288–294
   PubMedGoogle Scholar
• . Loh E, Sutton MS, Wun CC, . Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med. 1997;336(4):251–257
   PubMed Web of Science ®Google Scholar
• . Dries DL, Rosenberg YD, Waclawiw MA, Domanski MJ. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol. 1997;29(5):1074–1080
   PubMedGoogle Scholar
• . Massie BM, Collins JF, Ammon SE, . Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation. 2009;119(12):1616–1624
   PubMed Web of Science ®Google Scholar
• . Homma S, Thompson JL, Pullicino PM, . Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med. 2012;366(20):1859–1869
   PubMed Web of Science ®Google Scholar
• . Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol. 2007;49(7):797–802
   PubMed Web of Science ®Google Scholar
• . Petty GW, Khandheria BK, Meissner I, . Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. Mayo Clin Proc. 2006;81(5):602–608
   PubMed Web of Science ®Google Scholar
• . Schneider B, Hanrath P, Vogel P, Meinertz T. Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events. J Am Coll Cardiol. 1990;16(4):1000–1009
   PubMed Web of Science ®Google Scholar
• . Cabanes L, Mas JL, Cohen A, . Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke. 1993;24(12):1865–1873
   PubMed Web of Science ®Google Scholar
• . Mattioli AV, Aquilina M, Oldani A, Longhini C, Mattioli G. Atrial septal aneurysm as a cardioembolic source in adult patients with stroke and normal carotid arteries. A multicentre study. Eur Heart J. 2001;22(3):261–268
   PubMedGoogle Scholar
• . Berthet K, Lavergne T, Cohen A, . Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke. 2000;31(2):398–403
   PubMedGoogle Scholar
• . Pearson AC, Nagelhout D, Castello R, Gomez CR, Labovitz AJ. Atrial septal aneurysm and stroke: a transesophageal echocardiographic study. J Am Coll Cardiol. 1991;18(5):1223–1229
   PubMed Web of Science ®Google Scholar
• . Mas JL, Arquizan C, Lamy C, . Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345(24):1740–1746
   PubMed Web of Science ®Google Scholar
• . Pezzini A, Del Zotto E, Magoni M, . Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke. 2003;34(1):28–33
   PubMed Web of Science ®Google Scholar
• . Rajamani K, Chaturvedi S, Jin Z, . Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study. Stroke. 2009;40(7):2337–2342
   PubMedGoogle Scholar
• . Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology. 2000;55(8):1172–1179
   PubMed Web of Science ®Google Scholar
• . Homma S, DiTullio MR, Sacco RL, Sciacca RR, Mohr JP, Investigators P. Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale. Stroke. 2004;35(9):2145–2149
   PubMedGoogle Scholar
• . Meissner I, Khandheria BK, Heit JA, . Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol. 2006;47(2):440–445
   PubMed Web of Science ®Google Scholar
• . Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP, Investigators PiCSSP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation. 2002;105(22):2625–2631
   PubMed Web of Science ®Google Scholar
• . Kitsios GD, Dahabreh IJ, Abu Dabrh AM, Thaler DE, Kent DM. Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence. Stroke. 2012;43(2):422–431
   PubMed Web of Science ®Google Scholar
• . Furlan AJ, Reisman M, Massaro J, . Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366(11):991–999
   PubMed Web of Science ®Google Scholar
• . Rodan L, McCrindle BW, Manlhiot C, . Stroke recurrence in children with congenital heart disease. Ann Neurol. 2012;72(1):103–111
   PubMedGoogle Scholar
• . Menache CC, du Plessis AJ, Wessel DL, Jonas RA, Newburger JW. Current incidence of acute neurologic complications after open-heart operations in children. Ann Thorac Surg. 2002;73(6):1752–1758
   PubMedGoogle Scholar
• . Natowicz M, Kelley RI. Mendelian etiologies of stroke. Ann Neurol. 1987;22(2):175–192
   PubMedGoogle Scholar
• . Scharf RE, Hennerici M, Bluschke V, Lueck J, Kladetzky RG. Cerebral ischemia in young patients: it is associated with mitral valve prolapse and abnormal platelet activity in vivo? Stroke. 1982;13(4):454–458
   PubMedGoogle Scholar
• . Rice GP, Ebers GC, Bondar RL, Boughner DR. Mitral valve prolapse: a cause of stroke in children? Dev Med Child Neurol. 1981;23(3):352–356
   PubMed Web of Science ®Google Scholar
• . Kouvaras G, Bacoulas G. Association of mitral valve leaflet prolapse with cerebral ischaemic events in the young and early middle-aged patient. Q J Med. 1985;56(219):387–392
   PubMedGoogle Scholar
• . Barnett HJ, Boughner DR, Taylor DW, Cooper PE, Kostuk WJ, Nichol PM. Further evidence relating mitral-valve prolapse to cerebral ischemic events. N Engl J Med. 1980;302(3):139–144
   PubMed Web of Science ®Google Scholar
• . Burke A, Jeudy J, Virmani R. Cardiac tumours: an update: Cardiac tumours. Heart. 2008;94(1):117–123
   PubMedGoogle Scholar
• . Kandt RS, Gebarski SS, Goetting MG. Tuberous sclerosis with cardiogenic cerebral embolism: magnetic resonance imaging. Neurology. 1985;35(8):1223–1225
   PubMedGoogle Scholar
• . Furlan AJ, Craciun AR, Raju NR, Hart N. Cerebrovascular complications associated with idiopathic hypertrophic subaortic stenosis. Stroke. 1984;15(2):282–284
   PubMedGoogle Scholar